Both in Biotechnology
Iovance Biotherapeutics vs Tarsus Pharmaceuticals
Over the past year IOVA returned +330.5% and TARS returned +8.8%; their daily moves had a correlation of 0.26.
IOVA +330.5% TARS +8.8%Growth of $1, one year, split-adjusted
| Metric | IOVA | TARS |
|---|---|---|
| Price | $8.48 | $74.85 |
| Market cap | $3.84B | $3.50B |
| Today | −11.30% | +0.88% |
| 1 month | −40.4% | −0.8% |
| 6 months | +149.4% | +17.7% |
| Year to date | +210.6% | −8.6% |
| 1 year | +324.0% | +10.9% |
| Revenue growth (YoY) | +65.7% | +69.4% |
| Gross margin | 56.1% | 93.0% |
| Net margin | −47.6% | −10.7% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 5.8× |
| Net cash | $297.7M | $376.9M |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 46.7% |
| Short % of float | 15.2% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).